In recent years, scientists have found evidence confirming the aberrant expression of miRNAs in cancer patients compared to healthy individuals. The growing interest in the identification of non-invasive and specific diagnostic and prognostic molecular markers has identified microRNAs as potential candidates in cancer diagnosis, prognosis and treatment response. In the present study, we have analyzed the expression profile of circulating miR-21, -191 and -421 in peripheral blood of head and neck cancer patients (HNC) to investigate a possible modulation of mRNA levels by radiation and to identify the role of mRNA as biomarkers of cancer prognosis. Results showed a modulation of the microRNA expression at different time points after radiotherapy, suggesting that treatment may influence the release of circulating miRNAs depending also on the time interval elapsed since radiotherapy. The expression levels of miR-21, -191 and -421 were higher in blood of patients treated with radiotherapy alone after 6 months from the end of therapy and high levels of them seemed to correlate with the remission of the disease. The trends shown in this study confirmed that miRNAs could be useful prognosis markers and could provide preliminary data for further evaluation in predicting patients' response to radiotherapy by developing miRNA-based treatments to improve the sensitivity of cancer cells to radiotherapy.

译文

近年来,科学家发现了证据,证实了与健康个体相比,癌症患者中mirna的异常表达。对鉴定非侵入性和特异性诊断和预后分子标志物的兴趣日益浓厚,已将microRNAs确定为癌症诊断,预后和治疗反应的潜在候选者。在本研究中,我们分析了头颈癌患者 (HNC) 外周血中循环miR-21,-191和-421的表达谱,以研究辐射对mRNA水平的可能调节,并确定mRNA作为癌症预后生物标志物的作用。结果显示放疗后不同时间点microRNA表达的调节,表明治疗可能会影响循环mirna的释放,这也取决于放疗后经过的时间间隔。从治疗结束后的6个月后,单独接受放射治疗的患者血液中miR-21,-191和-421的表达水平较高,并且高水平似乎与疾病的缓解相关。本研究显示的趋势证实,miRNA可能是有用的预后标志物,并可以通过开发基于miRNA的治疗方法来提高癌细胞对放射治疗的敏感性,为进一步评估患者对放射治疗的反应提供初步数据。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录